1. Home
  2. ZAPP vs ONVO Comparison

ZAPP vs ONVO Comparison

Compare ZAPP & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZAPP
  • ONVO
  • Stock Information
  • Founded
  • ZAPP 2017
  • ONVO 2007
  • Country
  • ZAPP Thailand
  • ONVO United States
  • Employees
  • ZAPP N/A
  • ONVO N/A
  • Industry
  • ZAPP Motor Vehicles
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZAPP Consumer Discretionary
  • ONVO Health Care
  • Exchange
  • ZAPP Nasdaq
  • ONVO Nasdaq
  • Market Cap
  • ZAPP 8.3M
  • ONVO 7.2M
  • IPO Year
  • ZAPP N/A
  • ONVO N/A
  • Fundamental
  • Price
  • ZAPP $1.78
  • ONVO $0.38
  • Analyst Decision
  • ZAPP
  • ONVO
  • Analyst Count
  • ZAPP 0
  • ONVO 0
  • Target Price
  • ZAPP N/A
  • ONVO N/A
  • AVG Volume (30 Days)
  • ZAPP 89.5K
  • ONVO 89.1K
  • Earning Date
  • ZAPP 11-19-2024
  • ONVO 11-26-2024
  • Dividend Yield
  • ZAPP N/A
  • ONVO N/A
  • EPS Growth
  • ZAPP N/A
  • ONVO N/A
  • EPS
  • ZAPP N/A
  • ONVO N/A
  • Revenue
  • ZAPP N/A
  • ONVO $103,000.00
  • Revenue This Year
  • ZAPP N/A
  • ONVO $59.08
  • Revenue Next Year
  • ZAPP $53,347.33
  • ONVO $18.24
  • P/E Ratio
  • ZAPP N/A
  • ONVO N/A
  • Revenue Growth
  • ZAPP N/A
  • ONVO N/A
  • 52 Week Low
  • ZAPP $0.70
  • ONVO $0.35
  • 52 Week High
  • ZAPP $19.10
  • ONVO $1.74
  • Technical
  • Relative Strength Index (RSI)
  • ZAPP 29.06
  • ONVO 31.18
  • Support Level
  • ZAPP $1.62
  • ONVO $0.39
  • Resistance Level
  • ZAPP $2.08
  • ONVO $0.46
  • Average True Range (ATR)
  • ZAPP 0.19
  • ONVO 0.04
  • MACD
  • ZAPP 0.00
  • ONVO -0.01
  • Stochastic Oscillator
  • ZAPP 24.25
  • ONVO 1.54

About ZAPP Zapp Electric Vehicles Group Limited

Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Share on Social Networks: